United States Últimas notícias

Novocure (NASDAQ:NVCR) said its Optune Pax device has received CE Mark approval for treating adult patients with locally advanced pancreatic cancer of exocrine origin in combination with gemcitabine and nab-paclitaxel.

John Stoltzfus, chief investment strategist at Oppenheimer, explains why markets remain "resilient" in overcoming various economic and geopolitical challenges.

Redwire (NYSE:RDW) announced it has been awarded a contract by Taiwan Color Optics, a subsidiary of SemiLux International, to deliver its Penguin Mk2.5 VTOL uncrewed aerial system to the Taiwan Coast Guard.

Webull (NASDAQ:BULL), through its subsidiary Webull Thailand, signed an agreement to acquire Pi Securities, a Thai investment services firm with more than 50 years of market experience.

Ingredion (NYSE:INGR) completed the sale of a 51% equity interest in its Pakistan business, Rafhan Maize, for approximately $165 million.

Merck (NYSE:MRK) and AbbVie (NYSE:ABBV) are facing U.S. national security investigations over their clinical trial activities in China.

Iran reiterated its determination to oversee and control maritime traffic through the Strait of Hormuz ahead of a fresh round of talks in Qatar on formally ending its war with the US. Tyler Kendall reports on Bloomberg Television.

Oil is set for the biggest quarterly decline since the pandemic and Morgan Stanley is warning of a potential glut ahead as flows through the Strait of Hormuz accelerated following progress on a peace deal between the US and Iran. Alaric Nightengale reports on Bloomberg Television.

Santacruz Silver Mining (NASDAQ:SCZM) reported that an employee died following an incident at its Reserva mine in Bolivia on June 24, 2026.

Magnachip Semiconductor (NYSE:MX) appointed Chae Lee as Chief Executive Officer, effective July 1, 2026, marking a leadership change after nearly 11 months under interim CEO Camillo Martino.

Oklo (NYSE:OKLO) announced that it has acquired Creative Engineers, an industry leader in chemical process engineering with extensive expertise in sodium and alkali-metal systems.

BeOne Medicines (NASDAQ:ONC) announced positive topline results from the Phase 3 MANGROVE study evaluating BRUKINSA plus rituximab versus bendamustine plus rituximab in adult patients with previously untreated mantle cell lymphoma.